No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
OmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript
RBC Capital Reaffirms Their Buy Rating on OmniAb (OABI)
Analysts Offer Insights on Healthcare Companies: ALX Oncology Holdings (ALXO), Lantern Pharma (LTRN) and OmniAb (OABI)
Express News | OmniAb Inc : Leerink Partners Cuts Target Price to $12 From $13
10-Q: Quarterly report
Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, Vs. Street Est of $5.9M
04:32 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M